0KDJ fundamentals
An in-depth look to LAVIPHARM EUR0.3 operating, investing, and financing activities
0KDJ free cash flow for H2 23 is -3.97 M EUR. For 2023, 0KDJ free cash flow was -3.58 M EUR and operating cash flow was 539 k EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM